Six hundred endometrial laser ablations

Obstet Gynecol. 1995 Jan;85(1):24-9. doi: 10.1016/0029-7844(94)00326-9.

Abstract

Objective: To report the effectiveness and safety of endometrial laser ablation in the treatment of menorrhagia, as determined by detailed follow-up of 600 operations for at least 6 months.

Methods: Operative data from 600 endometrial laser ablations performed on 524 women were collected. Five hundred one (96%) of these women were followed with consultations and questionnaires. The mean duration of follow-up was 15 months (range 6-42).

Results: No major operative morbidity occurred. There were no cases of primary or secondary hemorrhage, uterine perforations with the operating instrument, or immediate laparotomy. A successful outcome was reported by 83.4% of patients. A second endometrial laser ablation was required in 14.3% of the women. Success increased with increasing age and low fluid absorption. Cavity length, operation time, duration of follow-up, and whether it was a first or second procedure were not associated with any difference in the success rate, although the hysterectomy rate tended to rise with increasing length of follow-up.

Conclusion: This study, the largest one published from a single institution, with a mean follow-up duration of 15 months, confirms that endometrial laser ablation is a safe and effective treatment for dysfunctional uterine bleeding.

Publication types

  • Clinical Trial

MeSH terms

  • Absorption
  • Adult
  • Age Factors
  • Amenorrhea / epidemiology
  • Amenorrhea / etiology
  • Body Fluids / metabolism
  • Catheter Ablation
  • Endometrium / surgery*
  • Female
  • Follow-Up Studies
  • Furosemide / administration & dosage
  • Humans
  • Hysterectomy
  • Intraoperative Care
  • Laser Therapy / adverse effects
  • Laser Therapy / methods*
  • Menorrhagia / etiology
  • Menorrhagia / metabolism
  • Menorrhagia / surgery*
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Regression Analysis
  • Reoperation
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Furosemide